Paclitaxel 100mg per vial

Paclitaxel protein-bound particles · PACLITAXEL 100 mg/20mL · Injection, Powder, Lyophilized, For Suspension · Intravenous · Exelan Pharmaceuticals Inc.

NDC 76282-0768-09 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: ANDA209657
TE code: AB
Approval date: Apr 10, 2025
Patents / exclusivity: None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Paclitaxel protein-bound particles (Injection, Powder, Lyophilized, For Suspension)

Labeler	Strength	First seen	Last seen
Cipla USA Inc.	PACLITAXEL 100 mg/20mL	Jul 15, 2026	Sep 2, 2026
Exelan Pharmaceuticals Inc.	PACLITAXEL 100 mg/20mL	Aug 12, 2026	Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Paclitaxel 100mg per vial — NDC 76282-0768-09," retrieved September 3, 2026, https://drugdashboards.com/drug/76282076809.

Free to cite with attribution — see how the data is put together.